Aurinia Pharmaceuticals Inc AUPH

16.44 (0.16) (0.96%) as of 25 Sep
Market cap
$2.2B
P/E
6.9×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
398.00 358.48 350.49 389.39 466.08 398.33 306.02 125.86 173.46 39.65
Receivables
41.45 36.54 24.09 13.48 15.41 0.80 0.37 0.22 0.11 0.09
Inventory
45.69 39.23 39.71 24.75 19.33 13.93 — — — —
Other current assets
1.08 1.13 1.03 1.33 0.80 5.65 6.73 4.98 1.34 1.25
Total current assets
491.97 446.60 424.80 442.54 513.32 419.43 315.14 132.85 175.25 41.42
Property, Plant, Equpment (Net)
2.11 2.73 3.35 3.65 4.42 4.79 0.09 0.04 0.03 0.03
Long-Term Investments
— — 0.20 — — 24.38 — — — —
Goodwill and Intangible Assets (Total)
3.76 4.36 4.98 6.43 8.40 9.33 8.86 12.62 14.12 15.55
Long Term Assets (Tax, Deferred)
176.19 — — — — — — — — —
Long-term assets (Other)
0.09 0.82 1.52 13.34 11.84 0.25 0.21 0.36 0.45 —
Total non-current assets
259.62 104.05 123.26 28.32 30.04 44.23 9.16 13.02 14.60 15.58
Total Assets
751.59 550.65 548.06 470.86 543.37 463.66 324.30 145.86 189.85 57.00
Accounts Payable
3.31 5.19 4.33 39.99 34.95 24.80 11.18 7.07 7.96 5.79
Accrued Expenses
66.62 64.97 50.06 — — — — — — —
Current Part of Capital Lease
16.52 14.05 14.61 — — — — — — —
Current Revenue (Deferred)
3.72 11.00 4.81 3.15 0.19 — 0.12 0.12 0.12 0.12
Other current liabilities
2.48 1.53 2.39 2.03 4.45 6.41 0.12 0.07 0.07 2.02
Total current liabilities
93.72 97.76 77.19 46.11 40.65 32.00 11.30 7.26 8.15 7.93
Long Term Debt (Total)
52.32 58.55 75.48 5.30 6.05 6.00 — — — —
Non-current Revenue (Deferred)
12.65 1.70 — — — 0.16 0.25 0.32 0.44 0.56
Non-current Liabilities (Other)
6.66 9.41 10.91 12.17 15.95 16.30 14.41 25.70 15.51 12.56
Total non-current liabilities
76.53 75.40 92.92 19.32 23.63 23.91 14.41 26.03 15.95 13.12
Total liabilities
170.26 173.17 170.11 65.43 64.28 55.91 25.70 33.29 24.10 21.05
Additional Paid In Capital
111.26 127.00 120.79 85.49 59.01 39.38 25.39 24.69 18.36 17.02
Common Stock (Net)
1,120.04 1,187.70 1,200.22 1,185.31 1,177.05 944.33 746.49 504.65 499.20 299.82
Retained Earnings
(649.37) (936.57) (942.32) (864.30) (756.12) (575.16) (472.48) (415.96) (351.84) (281.05)
Equity Equivalent
— — — — — — — — 0.91 0.97
Common Equity (Total)
581.33 377.48 377.95 405.44 479.09 407.75 298.60 112.58 165.74 35.95
Shareholders Equity (Total)
581.33 377.48 377.95 405.44 479.09 407.75 298.60 112.58 165.74 35.95
Shareholders Equity and Liabilities (Total)
751.59 550.65 548.06 470.86 543.37 463.66 324.30 145.86 189.85 57.00
Shares (Common)
132.32 140.83 143.83 142.27 141.60 126.73 111.80 85.50 84.05 52.81
Shareholders Equity (Tangible)
577.57 373.12 372.98 399.01 470.69 398.42 289.74 99.96 151.63 20.40
Net Debt
(345.67) (299.92) (275.01) (384.09) (460.03) (392.33) (306.02) (125.86) (173.46) (39.65)
Total Debt
52.32 58.55 75.48 5.30 6.05 6.00 — — — —

Fold the line items

In millions of $ except per-share values · columns are period end dates